| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Mycobacterium scrofulaceum |
- |
- |
15.6 － ? |
DuP-721  |
254 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
≤0.015 － ? |
RBx 8700 |
1084 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
0.06 － ? |
Rifampicin (Rifampin) |
1084 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
0.5 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
1084 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
0.5 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1084 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
1 － ? |
Ranbezolid (RBX 7644) |
1084 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
2.5 － ? |
Rifampicin (Rifampin) |
1218 |
| Mycobacterium scrofulaceum (ATCC 19981) |
- |
- |
2.8 － ? |
2-aminophenoxazine-3-one (Phx-3) |
1099 |
| Mycobacterium scrofulaceum (clinical isolate) |
- |
- |
≤0.015 － ? |
RBx 8700 |
1084 |
| Mycobacterium scrofulaceum (clinical isolate) |
- |
- |
1 － ? |
Rifampicin (Rifampin) |
1084 |
| Mycobacterium scrofulaceum (clinical isolate) |
- |
- |
2 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
1084 |
| Mycobacterium scrofulaceum (clinical isolate) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1084 |
| Mycobacterium scrofulaceum (clinical isolate) |
- |
- |
2 － ? |
Ranbezolid (RBX 7644) |
1084 |